Literature DB >> 9392314

Impact of HLA compatibility on survival of kidney transplants from unrelated live donors.

G Opelz1.   

Abstract

BACKGROUND: Kidney transplants from unrelated live donors have been reported to perform exceedingly well despite poor HLA compatibility. These results were extrapolated to indicate that HLA matching in cadaver kidney transplantation is superfluous provided the ischemic preservation time is kept very short.
METHODS: The influence of HLA matching on the outcome of 2281 transplants from unrelated live donors from 1986 to 1995 was analyzed at 198 transplant centers.
RESULTS: The 5-year transplant success rate was significantly associated with the number of HLA-A, -B, and -DR mismatches (P<0.0001). There was a significant impact on graft survival of mismatches at the class I HLA-A, and -B loci (P=0.001) as well as at the class II HLA-DR locus (P=0.005). In transplants from both spouses and nonspouses, cases with no HLA-DR mismatch were found more often than would be expected if transplant donors were selected by chance, which indicates that efforts of prospective HLA matching had been made.
CONCLUSIONS: The outcome of kidney transplants from unrelated live donors is strongly influenced by HLA compatibility. Short exposure of donor kidneys to ischemia does not eliminate the influence of HLA matching on graft survival.

Entities:  

Mesh:

Year:  1997        PMID: 9392314     DOI: 10.1097/00007890-199711270-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.

Authors:  O Cole; K Rigg; M Shehata
Journal:  Ann R Coll Surg Engl       Date:  2001-07       Impact factor: 1.891

2.  Incentive compatibility in kidney exchange problems.

Authors:  Silvia Villa; Fioravante Patrone
Journal:  Health Care Manag Sci       Date:  2009-12

3.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

4.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

5.  Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients.

Authors:  Oriol Bestard; Peter Nickel; Josep M Cruzado; Constanze Schoenemann; Olaf Boenisch; Anett Sefrin; Josep M Grinyó; Hans-Dieter Volk; Petra Reinke
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

Review 6.  [Living kidney donation - an overview].

Authors:  K Weigand; S Mühlstädt; N Mohammed; T Schaarschmidt; P Fornara; F Kawan
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

7.  Compatibility and kidney transplantation: the way to go.

Authors:  Ilias I N Doxiadis
Journal:  Front Immunol       Date:  2012-05-14       Impact factor: 7.561

8.  The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide.

Authors:  Robert C Williams; Gerhard Opelz; E Jennifer Weil; Chelsea J McGarvey; Harini A Chakkera
Journal:  Transplant Direct       Date:  2017-04-07

9.  Can PIRCHE-II Matching Outmatch Traditional HLA Matching?

Authors:  Christian Unterrainer; Bernd Döhler; Matthias Niemann; Nils Lachmann; Caner Süsal
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

10.  From Inflammation to the Onset of Fibrosis through A2A Receptors in Kidneys from Deceased Donors.

Authors:  Elena Guillén-Gómez; Irene Silva; Núria Serra; Francisco Caballero; Jesús Leal; Alberto Breda; Rody San Martín; Marçal Pastor-Anglada; José A Ballarín; Lluís Guirado; Montserrat M Díaz-Encarnación
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.